|
Eli
Lilly reduces human insulin price
Eli Lilly and Company [India] Pvt Ltd announced a price reduction
on its 100 IU/ml range of Huminsulin vials [Human Insulin-r DNA
origin].
Mangalam
plans three new products in anti-malarials
Mangalam Drugs & Organics Ltd (MDOL), one of the leading producers
of pain management drug nimesulide and anti-malarial bulk drugs
, is planning to launch three new products in the anti-malarial
segment as a part of the companies’ expansion plan.
Aurobindo
Pharma receives US FDA nod for metformin
Aurobindo Pharma Ltd has received US FDA approval for its Abbreviated
New Drug Application (ANDA) for metformin. Metformin is indicated
in the treatment of diabetes.
Suven’s
net profit increases by 9 per cent
Suven Life Sciences registered a net profit of Rs 113.98 for the
quarter ended December 31, 2004, a nine per cent increase compared
to the previous quarter ended September 30, 2004.
Indoco
Remedies Q2 net spurts by 166 per cent
Indoco Remedies Ltd has reported an encouraging performance for
the second quarter ended December 2004. Net sales rose by 15.2 per
cent at Rs 42.86 crore as compared to Rs 37.19 crore during the
corresponding period of last year.
Zydus
to host international symposium on genomics and proteomics
The Ramanbhai Foundation 2nd International Symposium dedicated to
’Current Trends in Pharmaceutical Sciences - Role of Genomics
and Proteomics’ will be held from January 23- 25, 2005 at the
Zydus Research Centre, Ahmedabad.
At
a Glance
|
